LOVELACE REGIONAL HOSPITAL-ROSWELL — History
CCN 320086 | 3-year financial timeline | COVID resilience: 69/100
🛡️ Public data only — no PHI permitted on this instance.
$63M
Latest Revenue (FY2022)
+10.3%
Revenue CAGR (3yr)
9.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $52M | $58M | $63M | +8.9% | +10.3% |
| Operating Expenses | $49M | $49M | $57M | +15.9% | +8.4% |
| Operating Margin | 6.1% | 14.9% | 9.3% | -37.1% | +23.5% |
| Net Income | $3M | $9M | $6M | -31.5% | +36.2% |
| Licensed Beds | 27 | 27 | 27 | +0.0% | +0.0% |
| Total Patient Days | 6,074 | 5,877 | 5,188 | -11.7% | -7.6% |
| Medicare Day % | 27% | 25% | 25% | +1.0% | -3.5% |
| Medicaid Day % | 0% | 1% | 1% | +15.1% | +109.9% |
COVID Impact & Recovery
Resilience Score: 69/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +21.7% ($52M → $63M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.3%
This Hospital
+7.6%
State Avg
Latest Margin
9.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $69M | 10.9% |
| FY2024 (proj) | $74M | 12.6% |
| FY2025 (proj) | $80M | 14.2% |